Neuropsiquiatra habla de mal “increíblemente raro” relacionado con vacuna de J & J

The FDA is monitoring the possibility that the Johnson and Johnson’s COVID-19 vaccine could be linked to an increased risk of developing Guillain-Barré Syndrome.

Fuente: Youtube